BRTX news

The company filed an exhibit 10.1 to its 8-K report, though specific terms of the agreement were not included in the provided text.

BioRestorative Therapies, Inc. executed a revolving loan agreement with an unnamed lender providing access to capital on an as-needed basis up to a maximum outstanding amount. The facility provides financial flexibility for the biotech company's operational and strategic needs.

BioRestorative Therapies filed a certificate of amendment to its articles of incorporation with the SEC. The filing indicates a corporate governance or structural modification but specific details of the amendment are not disclosed in the document reference.